¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
·Î±×ÀΠ ȸ¿ø°¡ÀÔ

ÆÄÆ®³Ê½º

ÀÚ·áµî·Ï
 

Àå¹Ù±¸´Ï

´Ù½Ã¹Þ±â

ÄÚÀÎÃæÀü

¢¸
  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (1 ÆäÀÌÁö)
    1

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (2 ÆäÀÌÁö)
    2

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (3 ÆäÀÌÁö)
    3

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (4 ÆäÀÌÁö)
    4

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (5 ÆäÀÌÁö)
    5

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (6 ÆäÀÌÁö)
    6

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (7 ÆäÀÌÁö)
    7

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (8 ÆäÀÌÁö)
    8


  • º» ¹®¼­ÀÇ
    ¹Ì¸®º¸±â´Â
    8 Pg ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
¢º
Ŭ¸¯ : Å©°Ôº¸±â
  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (1 ÆäÀÌÁö)
    1

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (2 ÆäÀÌÁö)
    2

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (3 ÆäÀÌÁö)
    3

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (4 ÆäÀÌÁö)
    4

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (5 ÆäÀÌÁö)
    5

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (6 ÆäÀÌÁö)
    6

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (7 ÆäÀÌÁö)
    7

  • ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç   (8 ÆäÀÌÁö)
    8



  • º» ¹®¼­ÀÇ
    (Å« À̹ÌÁö)
    ¹Ì¸®º¸±â´Â
    8 Page ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
  ´õºíŬ¸¯ : ´Ý±â
X ´Ý±â
Á¿ìÀ̵¿ : µå·¡±×

¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ È«¿ª ¿¹¹æÁ¢Á¾ ½ÇÅ ¹× È¿´É¿¡ °üÇÑ ¿ªÇÐÁ¶»ç

ÀÎ ¼â
¹Ù·Î°¡±â
Áñ°Üã±â Űº¸µå¸¦ ´­·¯ÁÖ¼¼¿ä
( Ctrl + D )
¸µÅ©º¹»ç ¸µÅ©ÁÖ¼Ò°¡ º¹»ç µÇ¾ú½À´Ï´Ù.
¿øÇÏ´Â °÷¿¡ ºÙÇô³Ö±â Çϼ¼¿ä
( Ctrl + V )
¿ÜºÎ°øÀ¯
ÆÄÀÏ  ¼º³², ±¤ÁÖ, ÀÌõÁö¿ªÀÇ ±¹¹ÎÇб³ ¾Æµ¿À» ´ë»óÀ¸·Î ÇÑ~.hwp   [Size : 70 Kbyte ]
ºÐ·®   8 Page
°¡°Ý  1,000 ¿ø


īƮ
´Ù¿î¹Þ±â
īī¿À ID·Î
´Ù¿î ¹Þ±â
±¸±Û ID·Î
´Ù¿î ¹Þ±â
ÆäÀ̽ººÏ ID·Î
´Ù¿î ¹Þ±â
µÚ·Î

ÀÚ·á¼³¸í
È«¿ª ¹é½ÅÀº 1954³â Enders¿Í Peebles°¡ óÀ½À¸·Î Àΰ£¿¡¼­ È«¿ª¹ÙÀÌ·¯½º¸¦ ¹è¾ç¿¡ ÀÇÇÏ¿© ºÐ¸®Çϴµ¥ ¼º°øÇÑ ÀÌ·¡ È«¿ª ¹é½Å¿¡ ´ëÇÑ ...
º»¹®/³»¿ë
È«¿ª ¹é½ÅÀº 1954³â Enders¿Í Peebles°¡ óÀ½À¸·Î Àΰ£¿¡¼­ È«¿ª¹ÙÀÌ·¯½º¸¦ ¹è¾ç¿¡ ÀÇÇÏ¿© ºÐ¸®Çϴµ¥ ¼º°øÇÑ ÀÌ·¡ È«¿ª ¹é½Å¿¡ ´ëÇÑ ¿¬±¸°¡ ±Þ¼Óµµ·Î ÁøÀüµÇ¾î 1963³â¿¡ ÇöÀç »ç¿ëÇϰí ÀÖ´Â ¾àµ¶È­ »ý ¹ÙÀÌ·¯½º ¹é½ÅÀÌ °³¹ßµÇ¾ú°í, ±¹³»¿¡¼­´Â 1965³â ÀÌÈÄ·Î ¿¹¹æÁ¢Á¾ÀÌ ½ÃÀÛÇÏ¿©, ÇöÀç Schwarz strain°ú ÀϺ»¿¡¼­ °³¹ßÇÑ AIK-C strain¹é½ÅÀ» Á¢Á¾Çϰí ÀÖ´Ù13). Á¢Á¾ÈÄ Àû¾îµµ 95%À̻󿡼­ Ç×ü°¡ »ý±â°í ¸é¿ª¹ÝÀÀµµ ÀÚ¿¬°¨¿°°ú ºñ½ÁÇÏ¿© 20-25³â Á¤µµ Ç×ü°¡ Áö¼ÓµÇ±â ¶§¹®¿¡ Ãß°¡ Á¢Á¾Àº ÇÊ¿äÄ¡ ¾Ê´Ù°í ÇÏ¿´°í, È«¿ªÀÇ ±ÙÀýÀÌ ±â´ëµÇ¾ú´Ù.
±×·¯³ª, ÃÖ±Ù ¹Ì±¹ µî ¿©·¯ ³ª¶ó¿¡¼­ ³ôÀº Á¢Á¾·ü¿¡µµ ºÒ±¸Çϰí Çе¿±â ÀÌÈÄÀÇ ¿¬·ÉÃþ¿¡¼­ È«¿ªÈ¯ÀÚÀÇ ¹ß»ýÀÌ Áõ°¡Çϰí ÀÖ´Ù. ¼±Áø±¹¿¡¼­µµ Àα¸°¡ ¹ÐÁýµÈ µµ½ÃÁö¿ª¿¡¼­ÀÇ È«¿ª Àü¿°ÀÇ °æ¿ì´Â Çе¿Àü±â ¾Æµ¿µµ Áß¿äÇÑ ºÎºÐÀ» Â÷ÁöÇϰí ÀÖÁö¸¸, ȯÀÚ ¹ß»ýÀÇ ÁÖµÈ Áý´ÜÀº Çе¿±â ¼Ò¾ÆÀÌ´Ù. ¹Ì±¹¿¡¼­´Â 5-9¼¼ ȯÀڵ鿡°Ô¼­ ÁÖ·Î ¸¹Àº ¹ß»ýÀ» º¸À̸ç3, 14-16) À̵éÀÌ º¸°íµÈ ȯÀÚÀÇ 50%ÀÌ»óÀ» Â÷ÁöÇϰí ÀÖ´Ù. 1989³â ÀÌÈÄ ¹Ì±¹ ¼Ò¾Æ°úÇÐȸ(American Academy of Pediatrics) °¨¿°À§¿øÈ¸¿¡¼­´Â 11-12¼¼¿¡, ¹Ì±¹CDC(Centers for Disea¡¦(»ý·«)
Âü°í¹®Çå
1) Markowitz LE, Orenstein WA : Measles vaccines ; In Bellanti JA(eds) : Pediatr Clin North Am 37:603-625, 1990
2) 90-94³âµµ ¹ýÁ¤ Àü¿°º´ ¹ß»ýÇöȲ. º¸°Çº¹ÁöºÎ, 1995
3) Center for Disease Control : Measles Surveillance Report No. 11, 1977-1981. Atlanta : CDC, 1983
4) Brunell PA, weigle K, Murphy MD, Shehal Z, Cobb E : Antibody response followiog Measles-Mumps-Rubella vaccine under conditions of customary use. JAMA 250:1409-1412, 1983
5) ±¹¸³º¸°Ç¿ø : °¨¿°º´ ¹ß»ýÁ¤º¸. Vol. 5(1) : 4-6, 1994
6) ±è¼ø±â, ÀÌÀαÔ, Çѽ±Ô, ¹ÚÁØÈñ, ÀåÀ±Á¤, ÃÖÁ¾¿î, ±èÁ¤±Ô, ¼Õº´°ü: 1993³âµµ ¼º³²Áö¿ª¿¡¼­ À¯ÇàÇÑ È«¿ªÀÇ ¿ªÇÐÀû ¿¬±¸. ¼Ò¾Æ°ú 38:180-187, 1995
7) Nkowane BM, Bart SW, Orenstein WA, Baltier M : Measles outbreak in a vaccinated school population : Epidemiology, chance of transmission and the role of vaccine failures, Am J Public Health 77:434-438, 1987
8) ¼Õ¿µ¸ð, ±èâÈÖ, ¿À¼ºÈñ, ÀÌȯÁ¾, ¹ÚÁ¾¿µ, ÀüÁ¤½Ä, ½Å»ó¸¸ : ÃÖ±ÙÀÇ È«¿ª À¯Çà¿¡ ´ëÇÑ °íÂû. ¼Ò¾Æ°ú 37:289-291, 1994
9) Ãֿ빬, ±èâȸ, ¼­Á¤±â, ¼Õ¿µ¸ð, ¿À¼ºÈñ, ÀÌȯÁ¾, ÀüÁ¤½Ä : ¿ì¸®³ª¶ó¿¡¼­ ÇöÀç ½ÃÇàµÇ°í ÀÖ´Â È«¿ª ¿¹¹æÁ¢Á¾¿¡ ´ëÇÑ ÀçÆò°¡. ¼Ò¾Æ°ú 34:435-440, 1991
10) Centers for Disease Control : Classification of measles case and categorization of measles elimination programs. MMWR 31:707-711, 1983
11) Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks Js, Bart KJ, Sirotkin B : Field evaluation of vaccine efficacy. Bull WHO 63:1055-1068, 1985
12) Orenstein WA, Bernier RH, Hinman AR : Assessing vaccine efficacy in the filed. Epidemiol Rev 10:212-241, 1988
13) ¿¹¹æÁ¢Á¾Áöħ¼­ : ´ëÇѼҾưúÇÐȸ °¨¿°À§¿øÈ¸ °³Á¤Áõº¸ 2ÆÇ, ´ëÇѼҾưúÇÐȸ, 1992, p 47-66
14) Babborr FL Jr, Gordon JE : Modern measles. Am J Med Sci 228:334-361, 1954
15) Black FL : Measles; In Even As (ed) : Viral Infections of Humans. Epidemiology and Control. 3rd ed, New York, Plenum, 1989, p 451-465
16) Langmuir AD : Medical importance of measles. Am J Dis Child 103:224-226, 1962
17) Hull HF, Williams PJ, Oldfield F : Measles mortality and vaccine efficacy in rural West Africa. Lancet 1: 972-975, 1983
18) Loening UE, Coovadia HM : Age specific occurrence rates of measles in urban, periurban, an rural encironments and implicatio for time of vaccination. Lancet 2:324-326, 1983
19) Dabis F, Sow A, Waldman RJ, Bikakouri P, Senega J, Madzou G, Jones TS : The epidemiology of measles in a partially vaccinated African city : Implications for immunization programs. Am J Epidemiol 127:171-178, 1988
20) Taylor WR, Mambu RK, Ma-Disu W, Weinman JM : Measles control effort in urban Africa complicated by high incidence of measles in the first year of life. Am J Epidemiol 127:788-794, 1988
21) Collaborative study by ministry of gealth of Kenya and World Health Organization. Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children. Bull WHO 55: 21-31, 1977
22) Halsey NA : The optimal age for administering measles vaccine in developing countries; In Halsey NA, de Quadros CA (eds) : Revent Advances in Immunization. A Biblographic Review (publication 451). Washington DC, Pan American Health Organezation. 1983, p 4-17
23) Halsey NA, Boullos R, Mode F, Andre J, Bowman L, Yeager RG, Toureau S, Rohde J, Boulos C : Responses to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. N Engl J Med 313:544-549, 1985
24) Black FL, Berman LL, Borgono JM, Capper RA, Carvalho AA, Collins C, Glover O, Hijazi Z, Jacobson E, Stevenson J, Vecchi N : Geographic variation in infant loss of maternal mealses antibody and in prevalence of rubella antibody. Am J Epidemiol 124:442-452, 1986
25) Baba R, Yabuuchi H, Takahashi M, Gershon AA, Ogra PL : Seroepidemiologic behavior of varicella zoster virus infection in a semiclosed community after introduction of VZV vaccine. J Pediatr 105:712-716, 1984
26) Marks JS, Hayden GF, Orenstein WA : Methodologic issues in the evaluation of vaccine effectiviness. Measles vaccine at 12 vs. 15 months. Am J Epidemiol 116:510-523, 1982
27) Albrecht P, Herrmann K, Burns GR : Role of virus strain in conventional and enganced measles plaque neutralization test. J Virol Methods 3:251-260, 1981
28) Curier RW, Hardy GE Jr, Conrad JL : Measles in previorsly vaccinated children : Evaluatio of an ortbreak. Am J Dis Child 124:854-7, 1972
29) Shasby DM, Shope TC, Downs H, Herrman HL, Polkwski J : Epidemic measles in a highly vaccinated population N Engl J Med 296:585-9, 1977
30) Wyll SA, White JJ : Measles in previously vaccinated children : An epidemiological study. JAMA 216:1306-1310, 1971
31) Krugman RD, Meyer BC, Parkman PD, Witte JJ, Meyer HM Jr : Importancy of live-virus vaccines as a result of improper handling in clinical practice. J Pediatr 85:512-514, 1974
32) Wassilak SCF, Orenstein WA, Strickland PL, Butler CA, Bart KJ : Continuing measles transmission in students despite a school-based outbreak control program. Am J Epidemiol 122:208-217, 1985
33) ¹Úȯ±Ô, À¯Á¤¿Ï, ±è¼Ò¿¬, ¼Õ¿µº¸, ÀÌ½Â±Ô : È«¿ª ¿ìÇà½Ã È«¿ª ¿¹¹æÁ¢Á¾¾ÆÀÇ È«¿ªÀÌȯ¿¡ °üÇÑ ¿¬±¸. ¼Ò¾Æ°ú 33: 1510-1515, 1990
34) Cherry JD, Feigin RD, Schakelford PG, Hinthorn DR, Schmidt RR : A clinical and serological study of 103 children with measles vaccine failure. J Pediatr 82:802-8, 1973
35) Nagy G, Kosa S, Takatsy S, Koller M : The use of IgM tests for analysis of the causes of measles vaccine failure : experience gained in an epidemic in Hungary in 1980 and 1981. J Med Virol 13:93-103, 1984
36) Gustafson TL, Lievens AW, Brunell PA, Moellenberg RG, Buttery CMG, Sehulster LM : Measles outbreak in a fully immunezed secondary-school population. N Engl J Med 316:771-774, 1987
37) ¼Õ¿µ¸ð, ȫâȣ, ÀÌ½Â±Ô : ÃÖ±Ù °­³² Áö¿ª¿¡¼­ À¯ÇàÇÑ È«¿ªÀÇ ¹ß»ý ¾ç»ó, 1989-1990. ´ëÇÑÀÇÇÐÇùȸÁö 34:960-968, 1991
38) Markowitz LE, Preblud SR, Orenstein WA, Rovia EZ, Adams NC, Hawkins CE, Hinman AR : Patterns of transmission in outbreaks in the United States, 1985-1986, N Engl J Med 320:75-81, 1989
39) Bishai DM, Bhatt S, Miller LT, Hayed GF : Vaccine storage practice in pediatric offices, Pediatrics 89:193-196, 1992
40) Krugman S : Present status of measles and rubella immunization in the United States : A medical progress report. J Pediatr 78:1-16, 1971
41) Bass JW, Halstead SB, Fischer GW, Podgore JK, Pearl WR, Schydlower M, Wiebe RA, Ching FM: Booster vaccination with further live attenuated measles vaccine. JAMA 235:31-34, 1976
42) Yeager AS, Davis JH, Ross LA, Harvey B : Measles immunization : Success and failure. JAMA 237:347-351, 1976
43) ±èÇý¿¬, ¹ÚÀÎÈ­, ȲÀ¯¹Ì, ÀÌÇ×Àç, ¹ÚÁÖ¹® : 1989 Àü±¹ ¿µÀ¯¾Æ ¿¹¹æÁ¢Á¾ ½ÇÅ Á¶»ç. Çѱ¹ º¸°Ç»çȸ ¿¬±¸¿ø 1989, p 34
44) Hopkins DR, Hinman AR, Koplan JP, Lane JM : The case for global measles eradication. Lancet 1:1396-1398, 1982
45) Hethcote HW : Measles and rubella in the United States. Am J Epidemiol 117:2-13, 1983
46) ±è¼ø±â, ÃÖÁ¾¿î, ¼Õº´°ü, ¹Ú½Â³², Á¤Ã¶¿µ, ¾È¿µ¹Î, ¹ÚÁ¾¿µ, ±è±¤³², À¯±â¾ç, Á¤¿ì°© : 1993³â À¯ÇàÇÑ È«¿ªÀÇ ¿ªÇÐÀû ¿¬±¸ ¹× MMR ¹é½ÅÀÇ ÀÓ»óÀû È¿´É. Á¦ 44Â÷ ´ëÇÑ ¼Ò¾Æ°úÇÐȸ Ãß°èÇмú´ëȸ ÃÊ·ÏÁý 1994, p83
47) ÀÌÇö±Ý: È«¿ª ¿¹¹æÁ¢Á¾¾ÆÀÇ °¨¿°. ´ëÇÑÀÇÇÐÇùȸÁö 20:301-305, 1977




📝 Regist Info
I D : lsyy******
Date : 2013-02-26
FileNo : 16064435

Cart